Patents by Inventor Kiyoshige Yoshida

Kiyoshige Yoshida has filed for patents to protect the following inventions. This listing includes patent applications that are pending as well as patents that have already been granted by the United States Patent and Trademark Office (USPTO).

  • Patent number: 11942895
    Abstract: A panel connected body includes a plurality of flat panels arranged in a matrix of m rows and n columns, where m?3 and n?3; and a plurality of row-direction connection portions and column-direction connection portions which connect together panels that are adjacent in a row direction and column direction, respectively. A first type row satisfying relationships D1?2L and Dy?Dy?1?2L and a second type row satisfying relationships Dn?2L and Dy?Dy+1+2L are alternately included, where Dy is a length along the column direction of the column-direction connection portions in a y-th column, and L is a thickness of the panels. The relationship E?WC?L is satisfied, where WC is a length along the column direction of the panels and E is a length along the column direction of the row-direction connection portions.
    Type: Grant
    Filed: March 30, 2023
    Date of Patent: March 26, 2024
    Assignee: ZEON CORPORATION
    Inventors: Yuki Hayashi, Kiyoshige Kojima, Masayoshi Yoshida
  • Patent number: 4575548
    Abstract: An occlusion compound of 2-nitroxymethyl-6-chloropyridine with .beta.-cyclodextrin is disclosed herein as well as a process for preparing the occlusion compound thereof. The occlusion compound of the present invention has a molar ratio of 2-nitroxymethyl-6-chloropyridine to .beta.-cyclodextrin of between about 1:1 and about 3:1. The present occlusion compound is nonvolatile, thereby overcoming the problems associated with the volatility of the 2-nitroxymethyl-6-chloropyridine for pharmacuetical preparations. The process of the present invention is carried out by reacting 2-nitroxymethyl-6-chloropyridine with .beta.-cyclodextrin either by kneading both compounds together with a small amount of a solvent or by mixing both compounds in an appropriate solvent, such as water. The occlusion compound is then precipitated, separated and further purified by conventional methods.
    Type: Grant
    Filed: September 26, 1984
    Date of Patent: March 11, 1986
    Assignee: Fujisawa Pharmaceutical Co., Ltd.
    Inventors: Yoshio Ueda, Fumio Shimojo, Kiyoshige Yoshida